Nifty

:

18268.40

Sensex

:

61350.26

143.00 (0.79%)
383.21 (0.63%)

Login

Nifty
Sensex

:
:

18268.40
61350.26

143.00 (0.79%)
383.21 (0.63%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

50/99

BSE: 524824 | NSE: BALPHARMA

Watchlist

NSE BSE

95.80

26-Oct-2021

Open
High
Low
Previous Close

97.35
98.90
95.50
96.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

34049
32.84
137.70
49.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

142.15
15.70
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

248.32
1.04%
1.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.96
1.82
3.65

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.99
10.73
6.87

PAT CAGR (%)

10 Years
5 Years
3 Years

9.24
22.05
7.74

P:E (Median)

8 Years
5 Years
3 Years

21.95
17.55
-

P:BV (Average)

8 Years
5 Years
3 Years

1.69
1.70
1.50

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.34
12.96
13.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 70.61 52.05 35.66% 0.00 33.77 -100.00% 62.70 43.00 45.81% 64.28 44.74 43.67%
Expenses 63.52 46.33 37.10% 0.00 32.97 -100.00% 56.47 41.27 36.83% 56.87 42.85 32.72%
EBITDA 7.10 5.72 24.13% 0.00 0.79 -100.00% 6.23 1.73 260.12% 7.41 1.89 292.06%
EBIDTM 10.05% 10.99% 0.00% 2.35% 9.94% 4.03% 11.53% 4.22%
Other Income 0.53 0.49 8.16% 0.00 1.62 -100.00% 0.64 0.98 -34.69% 0.39 0.41 -4.88%
Interest 2.97 2.78 6.83% 0.00 3.00 -100.00% 2.89 2.80 3.21% 3.17 3.32 -4.52%
Depreciation 1.69 1.49 13.42% 0.00 3.03 -100.00% 1.64 1.35 21.48% 1.80 1.33 35.34%
PBT 2.96 1.93 53.37% 0.00 -3.62 - 2.35 -1.44 - 2.84 -2.35 -
Tax 0.81 0.29 179.31% 0.00 0.53 -100.00% 0.80 0.57 40.35% 1.31 -0.77 -
PAT 2.15 1.64 31.10% 0.00 -4.15 - 1.55 -2.01 - 1.53 -1.58 -
PATM 3.04% 3.15% 0.00% -12.28% 2.47% -4.67% 2.38% -3.53%
EPS 1.45 1.11 30.63% 0.00 -2.80 - 1.05 -1.36 - 1.03 -1.07 -

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 70.83 52.13 35.87% 0.00 33.77 -100.00% 63.03 43.17 46.00% 64.56 44.99 43.50%
Expenses 63.34 47.05 34.62% 0.00 33.14 -100.00% 57.10 42.47 34.45% 57.46 43.15 33.16%
EBITDA 7.49 5.08 47.44% 0.00 0.63 -100.00% 5.93 0.70 747.14% 7.10 1.83 287.98%
EBIDTM 10.57% 9.75% 0.00% 1.87% 9.41% 1.63% 11.00% 4.07%
Other Income 0.14 0.16 -12.50% 0.00 1.17 -100.00% 0.19 0.41 -53.66% 0.06 0.03 100.00%
Interest 2.97 2.79 6.45% 0.00 3.02 -100.00% 2.89 2.81 2.85% 3.19 3.33 -4.20%
Depreciation 2.19 1.88 16.49% 0.00 3.59 -100.00% 2.03 1.42 42.96% 2.17 1.35 60.74%
PBT 2.46 0.57 331.58% 0.00 -4.80 - 1.20 -3.11 - 1.81 -2.83 -
Tax 0.81 0.29 179.31% 0.00 -0.07 - 0.80 0.60 33.33% 1.31 -0.84 -
PAT 1.65 0.28 489.29% 0.00 -4.74 - 0.40 -3.71 - 0.50 -1.99 -
PATM 2.33% 0.54% 0.00% -14.02% 0.64% -8.58% 0.77% -4.42%
EPS 1.09 0.30 263.33% 0.00 -3.34 - 0.22 -2.52 - 0.30 -1.29 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 249.31 170.67 223.08 207.66 225.96 197.66 187.13 178.87 147.91 139.69 Net Sales Growth - 46.08% -23.49% 7.43% -8.10% 14.32% 5.63% 4.62% 20.93% 5.88% Cost Of Goods Sold - 140.49 75.84 103.69 87.91 103.73 93.97 87.48 83.74 68.88 67.24 Gross Profit - 108.81 94.84 119.39 119.74 122.24 103.69 99.65 95.14 79.03 72.45 GP Margin - 43.64% 55.57% 53.52% 57.66% 54.10% 52.46% 53.25% 53.19% 53.43% 51.86% Total Expenditure - 222.81 163.66 202.59 184.76 205.85 180.52 169.60 161.00 130.70 124.88 Power & Fuel Cost - 4.70 4.68 6.38 6.06 6.17 4.65 4.54 4.39 3.52 3.50 % Of Sales - 1.89% 2.74% 2.86% 2.92% 2.73% 2.35% 2.43% 2.45% 2.38% 2.51% Employee Cost - 39.62 48.78 48.45 49.61 41.35 35.67 31.96 28.12 23.65 21.15 % Of Sales - 15.89% 28.58% 21.72% 23.89% 18.30% 18.05% 17.08% 15.72% 15.99% 15.14% Manufacturing Exp. - 19.21 15.94 20.42 17.99 21.25 19.69 20.77 18.23 14.03 14.86 % Of Sales - 7.71% 9.34% 9.15% 8.66% 9.40% 9.96% 11.10% 10.19% 9.49% 10.64% General & Admin Exp. - 4.97 7.09 8.61 10.26 16.08 13.69 12.31 11.54 9.40 8.44 % Of Sales - 1.99% 4.15% 3.86% 4.94% 7.12% 6.93% 6.58% 6.45% 6.36% 6.04% Selling & Distn. Exp. - 10.00 10.10 13.71 12.64 16.41 12.36 11.88 13.49 10.82 9.09 % Of Sales - 4.01% 5.92% 6.15% 6.09% 7.26% 6.25% 6.35% 7.54% 7.32% 6.51% Miscellaneous Exp. - 3.82 1.22 1.32 0.27 0.86 0.47 0.65 1.48 0.38 9.09 % Of Sales - 1.53% 0.71% 0.59% 0.13% 0.38% 0.24% 0.35% 0.83% 0.26% 0.44% EBITDA - 26.50 7.01 20.49 22.90 20.11 17.14 17.53 17.87 17.21 14.81 EBITDA Margin - 10.63% 4.11% 9.19% 11.03% 8.90% 8.67% 9.37% 9.99% 11.64% 10.60% Other Income - 2.69 3.63 2.75 1.67 3.39 1.50 1.19 0.65 0.66 1.08 Interest - 12.14 12.69 12.71 9.39 8.46 6.48 6.52 7.16 7.98 7.39 Depreciation - 7.26 7.03 6.12 6.73 6.46 6.97 7.00 4.74 4.81 4.13 PBT - 9.80 -9.08 4.41 8.45 8.59 5.18 5.20 6.63 5.09 4.37 Tax - 0.70 -0.17 -2.35 2.52 3.28 2.38 1.18 1.55 0.81 0.61 Tax Rate - 7.14% 1.87% -53.29% 29.82% 38.18% 45.95% 22.69% 23.38% 15.91% 13.96% PAT - 9.10 -8.90 6.76 5.94 5.31 2.81 4.02 5.07 4.28 3.76 PAT before Minority Interest - 9.10 -8.90 6.76 5.94 5.31 2.81 4.02 5.07 4.28 3.76 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 3.65% -5.21% 3.03% 2.86% 2.35% 1.42% 2.15% 2.83% 2.89% 2.69% PAT Growth - - - 13.80% 11.86% 88.97% -30.10% -20.71% 18.46% 13.83% EPS - 6.15 -6.01 4.57 4.01 3.59 1.90 2.72 3.43 2.89 2.54

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10
Net Sales - 250.53 171.09 225.01 209.29 228.91 198.32 187.16 178.87 114.29 106.23 Net Sales Growth - 46.43% -23.96% 7.51% -8.57% 15.42% 5.96% 4.63% 56.51% 7.59% Cost Of Goods Sold - 140.87 75.74 104.04 88.57 103.94 94.06 87.49 83.74 54.71 55.24 Gross Profit - 109.66 95.35 120.96 120.71 124.97 104.25 99.67 95.14 59.58 50.99 GP Margin - 43.77% 55.73% 53.76% 57.68% 54.59% 52.57% 53.25% 53.19% 52.13% 48.00% Total Expenditure - 225.88 166.07 207.33 191.95 214.10 183.46 170.05 161.00 104.36 100.95 Power & Fuel Cost - 4.98 4.76 6.38 6.07 6.17 4.66 4.54 4.39 2.90 2.13 % Of Sales - 1.99% 2.78% 2.84% 2.90% 2.70% 2.35% 2.43% 2.45% 2.54% 2.01% Employee Cost - 41.88 50.44 50.28 52.16 45.37 37.30 32.24 28.12 20.58 19.73 % Of Sales - 16.72% 29.48% 22.35% 24.92% 19.82% 18.81% 17.23% 15.72% 18.01% 18.57% Manufacturing Exp. - 18.61 15.80 20.28 18.03 21.44 19.80 20.78 18.23 11.24 8.90 % Of Sales - 7.43% 9.23% 9.01% 8.61% 9.37% 9.98% 11.10% 10.19% 9.83% 8.38% General & Admin Exp. - 5.45 7.48 9.27 11.21 16.82 13.98 12.43 11.54 5.41 4.71 % Of Sales - 2.18% 4.37% 4.12% 5.36% 7.35% 7.05% 6.64% 6.45% 4.73% 4.43% Selling & Distn. Exp. - 10.27 10.61 15.74 15.63 19.50 13.18 11.91 13.49 8.73 9.62 % Of Sales - 4.10% 6.20% 7.00% 7.47% 8.52% 6.65% 6.36% 7.54% 7.64% 9.06% Miscellaneous Exp. - 3.84 1.23 1.33 0.27 0.86 0.47 0.65 1.48 0.78 9.62 % Of Sales - 1.53% 0.72% 0.59% 0.13% 0.38% 0.24% 0.35% 0.83% 0.68% 0.58% EBITDA - 24.65 5.02 17.68 17.34 14.81 14.86 17.11 17.87 9.93 5.28 EBITDA Margin - 9.84% 2.93% 7.86% 8.29% 6.47% 7.49% 9.14% 9.99% 8.69% 4.97% Other Income - 1.14 1.85 1.01 1.73 3.04 1.28 1.17 0.65 0.79 2.94 Interest - 12.16 12.73 12.74 9.41 8.49 6.48 6.52 7.16 6.79 6.26 Depreciation - 9.52 7.68 6.16 6.77 6.49 7.01 7.02 4.74 2.90 2.86 PBT - 4.10 -13.53 -0.20 2.88 2.87 2.65 4.74 6.63 1.04 -0.91 Tax - -0.61 -0.64 -2.36 2.51 3.27 2.39 1.19 1.55 0.63 0.52 Tax Rate - -14.88% 4.73% 1180.00% 87.15% 113.94% 90.19% 25.11% 23.38% 60.58% -57.14% PAT - 4.74 -12.22 3.79 2.79 1.75 1.41 3.62 5.07 0.41 -1.43 PAT before Minority Interest - 4.71 -12.89 2.15 0.38 -0.40 0.26 3.55 5.07 0.41 -1.43 Minority Interest - 0.03 0.67 1.64 2.41 2.15 1.15 0.07 0.00 0.00 0.00 PAT Margin - 1.89% -7.14% 1.68% 1.33% 0.76% 0.71% 1.93% 2.83% 0.36% -1.35% PAT Growth - - - 35.84% 59.43% 24.11% -61.05% -28.60% 1,136.59% - EPS - 3.20 -8.26 2.56 1.89 1.18 0.95 2.45 3.43 0.28 -0.97

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 79.32 65.94 76.86 72.23 66.59 56.70 55.60 50.05 44.62 40.06 Share Capital 14.82 14.17 14.17 14.17 14.17 12.87 12.87 11.11 10.57 10.57 Total Reserves 63.56 51.77 62.69 58.06 52.41 41.81 40.71 37.20 32.84 29.48 Non-Current Liabilities 35.35 33.42 37.24 45.53 29.94 26.02 16.33 17.92 12.55 14.79 Secured Loans 23.93 22.93 28.76 33.25 12.76 10.81 6.11 6.58 1.00 5.81 Unsecured Loans 0.00 0.22 0.00 1.43 5.04 5.13 0.53 1.39 0.67 0.28 Long Term Provisions 3.97 3.55 2.66 2.02 3.35 2.23 1.65 1.06 0.83 0.64 Current Liabilities 146.87 139.95 143.06 133.33 122.32 110.61 92.22 86.77 92.67 86.32 Trade Payables 48.55 39.45 47.49 49.95 53.55 46.75 38.49 33.53 32.06 26.92 Other Current Liabilities 22.30 29.40 26.55 31.73 15.42 11.53 11.77 8.66 14.97 13.96 Short Term Borrowings 75.05 70.61 68.06 49.29 52.05 50.09 40.14 42.75 44.36 44.53 Short Term Provisions 0.97 0.49 0.96 2.37 1.29 2.24 1.83 1.83 1.28 0.91 Total Liabilities 261.54 239.31 257.16 251.09 218.85 193.33 164.15 154.74 149.84 141.17 Net Block 52.65 56.14 56.94 58.28 59.72 55.95 51.90 55.18 51.83 52.90 Gross Block 86.13 82.36 76.19 71.43 66.14 105.77 96.00 91.28 83.19 79.49 Accumulated Depreciation 33.48 26.23 19.25 13.15 6.42 49.82 44.10 36.10 31.36 26.59 Non Current Assets 68.34 70.60 68.66 69.62 68.49 68.89 59.50 59.63 56.82 56.68 Capital Work in Progress 0.00 0.11 0.06 0.21 1.70 3.93 0.77 0.25 0.87 0.41 Non Current Investment 8.40 7.42 7.44 7.44 0.02 1.18 1.09 0.02 0.02 0.02 Long Term Loans & Adv. 4.80 5.38 1.68 3.13 6.59 7.52 5.39 3.95 3.82 3.18 Other Non Current Assets 2.49 1.56 2.54 0.55 0.46 0.32 0.34 0.24 0.28 0.17 Current Assets 193.20 168.71 188.50 181.48 150.35 124.44 104.65 95.12 93.02 84.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 60.12 67.55 69.52 66.17 54.37 41.61 35.77 31.71 33.69 33.66 Sundry Debtors 69.44 51.66 65.69 64.06 61.01 56.82 44.99 45.49 43.44 38.19 Cash & Bank 3.72 2.95 4.09 4.02 4.61 4.46 4.54 3.02 4.53 3.03 Other Current Assets 59.92 7.44 2.36 0.23 30.37 21.54 19.35 14.89 11.36 9.61 Short Term Loans & Adv. 50.43 39.11 46.85 47.00 29.53 20.12 18.00 13.96 10.89 9.09 Net Current Assets 46.33 28.76 45.45 48.15 28.03 13.83 12.42 8.35 0.35 -1.83 Total Assets 261.54 239.31 257.16 251.10 218.84 193.33 164.15 154.75 149.84 141.16

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10
Shareholder's Funds 53.58 52.43 66.64 64.99 62.45 54.90 55.20 50.05 36.18 35.76 Share Capital 14.82 14.17 14.17 14.17 14.17 12.87 12.87 11.11 10.48 10.48 Total Reserves 37.82 38.25 52.47 50.82 48.27 40.01 40.31 37.20 25.50 25.09 Non-Current Liabilities 34.19 33.56 37.85 45.57 30.02 45.12 16.34 17.92 64.54 60.66 Secured Loans 23.93 22.93 28.76 33.25 12.76 15.24 6.11 6.58 53.76 54.41 Unsecured Loans 0.00 0.22 0.00 1.43 5.04 19.71 0.53 1.39 3.97 0.01 Long Term Provisions 4.07 3.62 2.71 2.05 3.42 2.28 1.65 1.06 0.00 0.00 Current Liabilities 152.53 159.49 163.24 154.40 143.24 111.19 92.36 86.77 34.59 27.78 Trade Payables 47.17 38.67 47.34 49.96 54.43 46.85 38.53 33.53 27.02 22.07 Other Current Liabilities 23.57 30.69 27.86 33.77 16.45 12.01 11.86 8.66 6.03 4.73 Short Term Borrowings 80.82 89.63 87.08 68.31 71.07 50.09 40.14 42.75 0.00 0.00 Short Term Provisions 0.98 0.50 0.96 2.37 1.29 2.24 1.83 1.83 1.53 0.99 Total Liabilities 240.07 238.38 261.31 260.17 233.33 211.03 163.87 154.74 135.31 124.20 Net Block 68.59 70.71 70.39 71.48 59.98 56.23 52.20 55.18 54.26 54.98 Gross Block 105.10 97.70 89.76 84.71 66.44 106.10 95.14 90.11 76.86 74.11 Accumulated Depreciation 36.52 27.00 19.37 13.23 6.46 49.87 42.95 34.93 22.60 19.13 Non Current Assets 75.93 81.02 78.26 75.41 68.78 68.03 58.74 59.63 54.40 55.00 Capital Work in Progress 0.00 3.32 3.63 0.21 1.70 3.93 0.77 0.25 0.13 0.00 Non Current Investment 0.00 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 4.86 5.43 1.69 3.15 6.61 7.54 5.42 3.95 0.00 0.00 Other Non Current Assets 2.49 1.56 2.54 0.55 0.46 0.32 0.34 0.24 0.00 0.00 Current Assets 164.15 157.37 183.05 184.77 164.55 143.00 105.12 95.12 80.90 69.20 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 60.39 67.71 69.75 66.49 54.73 41.75 35.82 31.71 32.21 28.62 Sundry Debtors 67.20 49.60 64.70 64.05 61.80 56.94 44.98 45.49 37.02 31.92 Cash & Bank 3.85 3.13 4.32 4.15 4.71 4.63 5.49 3.02 2.23 1.61 Other Current Assets 32.71 4.07 0.70 0.24 43.31 39.66 18.83 14.89 9.44 7.05 Short Term Loans & Adv. 28.02 32.85 43.58 49.83 42.45 38.45 17.48 13.96 5.56 4.59 Net Current Assets 11.61 -2.12 19.81 30.36 21.31 31.81 12.77 8.35 46.31 41.42 Total Assets 240.08 238.39 261.31 260.18 233.33 211.03 163.86 154.75 135.30 124.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 10.24 21.71 11.55 12.57 6.36 1.28 14.38 13.31 16.14 12.94 PBT 9.80 -9.08 4.41 8.45 8.59 5.18 5.20 6.63 5.09 4.37 Adjustment 17.44 16.69 15.67 15.08 14.73 11.21 11.67 10.43 11.67 10.09 Changes in Working Capital -16.89 14.27 -6.16 -9.69 -15.56 -14.32 -1.18 -2.59 0.87 -1.05 Cash after chg. in Working capital 10.35 21.89 13.92 13.84 7.77 2.08 15.69 14.47 17.63 13.41 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.11 -0.17 -2.38 -1.27 -1.40 -0.80 -1.31 -1.16 -1.48 -0.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -6.66 -3.16 -11.98 -15.59 -7.96 -13.73 -6.07 -7.30 -4.02 -2.22 Net Fixed Assets -3.66 -6.22 -4.61 -3.80 41.86 -12.93 -5.24 -7.47 -4.16 -3.99 Net Investments -0.98 0.02 0.00 -7.42 1.16 -0.09 -1.07 0.00 0.00 0.04 Others -2.02 3.04 -7.37 -4.37 -50.98 -0.71 0.24 0.17 0.14 1.73 Cash from Financing Activity -3.36 -19.94 0.05 3.53 1.74 12.38 -6.80 -7.52 -10.62 -9.66 Net Cash Inflow / Outflow 0.22 -1.38 -0.38 0.51 0.15 -0.07 1.51 -1.51 1.51 1.06 Opening Cash & Equivalents 0.68 2.20 2.58 2.07 4.46 4.54 3.02 4.53 3.03 1.97 Closing Cash & Equivalent 0.89 0.68 2.20 2.58 4.61 4.46 4.54 3.02 4.53 3.03

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10
Cash From Operating Activity 21.78 23.24 7.76 0.58 6.31 -19.35 14.53 13.31 4.61 -5.22 PBT 4.10 -13.53 -0.20 2.88 2.87 2.65 4.74 6.63 1.04 -0.91 Adjustment 21.14 19.01 17.41 15.14 14.79 11.46 11.69 10.43 9.49 7.12 Changes in Working Capital -3.35 17.94 -7.07 -16.18 -9.95 -32.66 -0.59 -2.59 -6.10 -10.70 Cash after chg. in Working capital 21.89 23.42 10.13 1.84 7.72 -18.55 15.84 14.47 4.43 -4.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.11 -0.17 -2.38 -1.27 -1.40 -0.80 -1.31 -1.16 0.18 -0.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.98 -4.71 -8.04 -3.56 -7.96 -13.88 -5.30 -7.30 -1.59 4.61 Net Fixed Assets -3.66 -6.22 -4.61 -3.80 41.86 -12.93 -5.24 -15.62 -2.86 -6.26 Net Investments -0.98 0.02 0.00 -7.42 1.16 -0.09 -1.07 0.04 0.00 0.03 Others -0.34 1.49 -3.43 7.66 -50.98 -0.86 1.01 8.28 1.27 10.84 Cash from Financing Activity -16.63 -19.97 0.01 3.53 -5.94 32.37 -6.80 -7.52 -2.40 0.74 Net Cash Inflow / Outflow 0.17 -1.44 -0.27 0.55 -7.58 -0.86 2.43 -1.51 0.62 0.13 Opening Cash & Equivalents 0.86 2.44 2.71 2.16 -17.72 5.49 3.02 4.53 1.61 1.49 Closing Cash & Equivalent 1.02 0.86 2.44 2.71 -25.30 4.63 5.45 3.02 2.23 1.61

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 52.88 46.53 54.23 50.97 46.98 42.48 41.63 43.48 41.06 37.88 ROA 3.63% -3.59% 2.66% 2.53% 2.58% 1.57% 2.52% 3.33% 2.94% 2.72% ROE 12.61% -12.47% 9.07% 8.56% 8.76% 5.18% 7.90% 11.06% 10.26% 9.84% ROCE 12.57% 2.09% 9.95% 11.76% 12.77% 10.07% 11.30% 13.77% 13.39% 12.27% Fixed Asset Turnover 2.96 2.15 3.02 3.05 2.70 2.00 2.04 2.09 1.85 1.83 Receivable days 88.65 125.48 106.15 108.76 92.68 92.06 86.60 89.17 99.15 96.48 Inventory Days 93.46 146.56 111.00 104.83 75.50 69.97 64.59 65.58 81.80 84.52 Payable days 76.12 92.64 88.56 101.97 90.67 90.60 79.18 78.99 85.48 77.58 Cash Conversion Cycle 105.98 179.41 128.58 111.61 77.50 71.43 72.02 75.75 95.48 103.42 Total Debt/Equity 1.33 1.51 1.36 1.25 1.11 1.28 0.92 1.08 1.23 1.43 Interest Cover 1.81 0.29 1.35 1.90 2.02 1.80 1.80 1.93 1.64 1.59

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 11 Mar 10
Book Value (Rs.) 35.52 36.99 47.02 45.86 44.06 41.09 41.32 43.48 34.33 33.94 ROA 1.97% -5.16% 0.83% 0.15% -0.18% 0.14% 2.23% 3.50% 0.31% -1.16% ROE 8.97% -21.65% 3.27% 0.59% -0.69% 0.49% 7.00% 12.03% 1.14% -4.22% ROCE 9.72% -0.44% 6.88% 7.45% 7.59% 7.35% 10.88% 14.05% 8.51% 6.31% Fixed Asset Turnover 2.47 1.83 2.58 2.80 2.72 2.01 2.06 2.18 1.60 1.58 Receivable days 85.08 121.92 104.42 108.60 92.23 91.87 86.58 82.73 104.23 99.58 Inventory Days 93.31 146.63 110.50 104.61 74.94 69.91 64.63 64.10 91.99 85.43 Payable days 72.54 90.28 86.70 99.47 88.16 89.31 79.05 72.93 89.00 77.88 Cash Conversion Cycle 105.86 178.27 128.22 113.74 79.02 72.47 72.17 73.90 107.22 107.13 Total Debt/Equity 2.09 2.26 1.85 1.69 1.49 1.68 0.93 1.08 1.60 1.53 Interest Cover 1.34 -0.06 0.98 1.31 1.34 1.41 1.73 1.93 1.15 0.86

Top Investors:

Annual Reports:

News Update:

Bal Pharma poised to strengthen its position in diabetes segment
28th Sep 2021, 14:01 PM

Gliclazide, API is a sulfonyl urea component used for treating type 2 Diabetes, has been an important contributor in the company’s earnings
Read More
Bal Pharma reports around 4-fold jump in Q1 consolidated net profit
11th Aug 2021, 13:09 PM

Total consolidated income of the company increased by 35.72% at Rs 70.96 crore for Q1FY22
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback